000 | 02052nam a22001937a 4500 | ||
---|---|---|---|
008 | 240328b2011 |||||||| |||| 00| 0 eng d | ||
020 | _a9781493961757 | ||
082 | _a576.85 SNY-R | ||
100 | _aSnyder, Richard O. | ||
245 |
_aAdeno-associated virus : _bmethods and protocols edited by _cRichard O. Snyder and Philippe Moullier |
||
260 |
_aNew York _bSpringer _c2011 |
||
300 | _a462p. | ||
440 | _aMethods in molecular biology | ||
500 | _aToday, progress in rAAV-mediated gene transfer is so robust that long-term, efficient, and regulatable transgene expression is reproducibly achieved in large animal models. The complexity of gene transfer agents in the context of their clinical use requires investigators from a wide variety of backgrounds to have an understanding ― or at least an appreciation of ― the regulatory environment and constraints that affect vector design, manufacturing, pre-clinical testing, and clinical use, with an emphasis on patient protection. In Adeno-Associated Virus: Methods and Protocols, experts from the United States and Europe have contributed current knowledge of this multi-dimensional field relating to the biology of AAV, rAAV vector design, vector manufacturing and product testing, performance of rAAV vectors in major organs, rAAV-related immunological issues, design of animal and clinical studies, and clinical experience. Written in the successful Methods in Molecular Biology™ series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible protocols, and notes on troubleshooting and avoiding known pitfalls. Authoritative and accessible, Adeno-Associated Virus: Methods and Protocols provides a complete and comprehensive understanding of this multi-disciplinary and rapidly progressing field. | ||
650 | _aGene therapy--Laboratory manuals. | ||
650 | _aGenetic transformation--Laboratory manuals. | ||
650 | _aParvoviruses--Laboratory manuals. | ||
650 | _aGenetic vectors. | ||
999 |
_c92215 _d92215 |